Get started
Shukra Pharmaceuticals Ltd.Shukra Pharmaceuticals Ltd.Shukra Pharmaceuticals Ltd.

Shukra Pharmaceuticals Ltd.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with Shukra Pharmaceuticals Ltd.



Key stats


Market capitalization
‪14.51 B‬ INR
Dividend yield (indicated)
0.03%
Price to earnings Ratio (TTM)
65.80
Basic EPS (TTM)
0.50 INR
Net income (FY)
‪220.58 M‬ INR
Revenue (FY)
‪567.27 M‬ INR
Shares float
‪46.74 M‬
Beta (1Y)
1.17

Profile


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Daksheshbhai R. Shah
Website
shukrapharmaceuticals.com
Headquarters
Ahmedabad
Founded
1993
ISIN
INE551C01044
FIGI
BBG000DM6JG1
Identifiers
ISIN INE551C01044
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of SHUKRAPHAR is 31.50 INR — it has decreased by −0.76% in the past 24 hours. Watch Shukra Pharmaceuticals Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Shukra Pharmaceuticals Ltd. stocks are traded under the ticker SHUKRAPHAR.
SHUKRAPHAR stock has fallen by −2.96% compared to the previous week, the month change is a 9.50% rise, over the last year Shukra Pharmaceuticals Ltd. has showed a 52.03% increase.
SHUKRAPHAR reached its all-time high on Dec 19, 2025 with the price of 65.26 INR, and its all-time low was 0.12 INR and was reached on Nov 7, 2013. View more price dynamics on SHUKRAPHAR chart.
See other stocks reaching their highest and lowest prices.
SHUKRAPHAR stock is 9.22% volatile and has beta coefficient of 1.17. Track Shukra Pharmaceuticals Ltd. stock price on the chart and check out the list of the most volatile stocks — is Shukra Pharmaceuticals Ltd. there?
Today Shukra Pharmaceuticals Ltd. has the market capitalization of ‪14.38 B‬, it has decreased by −2.24% over the last week.
Yes, you can track Shukra Pharmaceuticals Ltd. financials in yearly and quarterly reports right on TradingView.
SHUKRAPHAR net income for the last quarter is ‪−17.16 M‬ INR, while the quarter before that showed ‪203.65 M‬ INR of net income which accounts for 0.00% change. Track more Shukra Pharmaceuticals Ltd. financial stats to get the full picture.
Yes, SHUKRAPHAR dividends are paid annually. The last dividend per share was 0.01 INR. As of today, Dividend Yield (TTM)% is 0.03%. Tracking Shukra Pharmaceuticals Ltd. dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Shukra Pharmaceuticals Ltd. EBITDA is ‪287.35 M‬ INR, and current EBITDA margin is 50.66%. See more stats in Shukra Pharmaceuticals Ltd. financial statements.
Like other stocks, SHUKRAPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Shukra Pharmaceuticals Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Shukra Pharmaceuticals Ltd. technincal analysis shows the strong sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Shukra Pharmaceuticals Ltd. stock shows the buy signal. See more of Shukra Pharmaceuticals Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.